Favourable Results of Patritumab Deruxtecan in Patients with Leptomeningeal Metastatic Disease of Solid Tumours By Ogkologos - July 21, 2025 258 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the TUXEDO-3 study Source RELATED ARTICLESMORE FROM AUTHOR In Memory of Hernán Cortés-Funes: Former ESMO President and Pioneer in Medical Oncology Immune Pathways Help Identify Patients with Cancer and HIV Most Likely to Experience Reservoir Decay with Anti-PD1 Therapy Shaping Future Oncology Leaders: ESMO Broadens Its Career Development Opportunities MOST POPULAR Expressive Writing, What is It? May 12, 2021 Jiffy Lube Surprises Volunteer Who Drives Cancer Patients To Treatment With... December 11, 2019 Biomedical Engineering Student Invents Device for At-Home Breast Cancer Screening January 6, 2021 Radiopharmaceuticals: Radiation Therapy Enters the Molecular Age October 26, 2020 Load more HOT NEWS Evaluating Targeted Therapy for People With Advanced Gastric or Gastroesophageal Junction... Drinking Alcohol, Often Heavily, Common among People with Cancer and Long-Term... Trial Should Change Care for AIDS-Related Kaposi Sarcoma in Sub-Saharan Africa Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;
